|
End-of-day quote
Nasdaq
2026-09-17
|
5-day change | 1st Jan Change | ||
| 1.910 USD | 0.00% |
|
+6.11% | -78.85% |
| 09-14 | EnGene Therapeutics Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 07:00 AM | |
| 09-08 | EnGene Therapeutics Inc. Provides Clinical Updates | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENGENE THERAPEUTICS INC. | Bio Therapeutic Drugs | 0.00% | +6.11% | -78.85% | -72.56% | - | 128M |  |  | |
- Stock Market
- Stocks
- ENGN Stock
- Charts enGene Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
